PYXS vs WBA
Pyxis Oncology Inc (PYXS) versus WBA (WBA) — a side-by-side from cached financials, not a winner call.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
WBA (WBA) common stock.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
WBA does not have a complete income-statement cache yet.
PYXS currently screens at market cap $109.6M.
Not investment advice. Open the PYXS and WBA stock pages for the full models.
Not investment advice.